The Fund
The Fund is a non-diversified, closed-end investment company whose objective is to seek long-term capital appreciation primarily through investment in equity and equity-linked securities of Swiss companies.
The Fund is listed on the New York Stock Exchange under the symbol "SWZ".
Share/NAV Price
| SMI | ||||
| SPI | ||||
| NAV PER SHARE | ||||
| SWZ Stock Price | ||||
| Holding | Shares | % of Portfolio |
|---|---|---|
| Nestle | 209,105 | 21.05% |
| Roche Holding | 45,700 | 12.46% |
| Novartis AG | 150,000 | 10.60% |
| Richemont (CIE Fin) | 51,000 | 5.03% |
| Zurich Insurance Group AG | 11,430 | 4.10% |
| Partners Group HLG | 3,550 | 3.17% |
| UBS GROUP AG | 216,000 | 2.89% |
| SIG Group AG | 131,300 | 2.81% |
| Logitech Intl | 52,800 | 2.43% |
| Tecan Group AG | 7,980 | 2.32% |
Percentages based on the Fund's July 31, 2022 Total Net Assets.
Schroders is a world-class asset manager operating from 38 locations across Europe, the Americas, Asia and the Middle East.
Schroder Investment Management North America Inc. took over management of The Swiss Helvetia Fund on July 1, 2014. For additional information regarding Schroders, please visit www.schroders.com/us or call 800-730-2932.
Contact Us
